Form 8-K - Current report:
SEC Accession No. 0001493152-24-048611
Filing Date
2024-12-04
Accepted
2024-12-04 09:00:18
Documents
16
Period of Report
2024-11-27
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43905
2 ex99-1.htm EX-99.1 21414
3 ex99-1_001.jpg GRAPHIC 5047
  Complete submission text file 0001493152-24-048611.txt   301866

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE aimd-20241127.xsd EX-101.SCH 3737
5 XBRL DEFINITION FILE aimd-20241127_def.xml EX-101.DEF 29986
6 XBRL LABEL FILE aimd-20241127_lab.xml EX-101.LAB 36618
7 XBRL PRESENTATION FILE aimd-20241127_pre.xml EX-101.PRE 27009
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5621
Mailing Address AINOS, INC. 8880 RIO SAN DIEGO DRIVE SUITE 800 SAN DIEGO CA 92108
Business Address AINOS, INC. 8880 RIO SAN DIEGO DRIVE SUITE 800 SAN DIEGO CA 92108 858-869-2986
Ainos, Inc. (Filer) CIK: 0001014763 (see all company filings)

EIN.: 751974352 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41461 | Film No.: 241525002
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)